montelukast


Also found in: Medical, Wikipedia.
Related to montelukast: Montelukast sodium, Singulair

mon·te·lu·kast

 (mŏn′tə-lo͞o′kăst)
n.
A drug that reduces the inflammatory response by acting as a leukotriene receptor antagonist, and is used to treat the signs and symptoms of asthma.

[monte-, of unknown origin + -lukast, leukotriene receptor antagonist suff.; see zafirlukast.]
Translations

montelukast

n montelukast m
References in periodicals archive ?
a subsidiary of Ajanta Pharma Limited, India, announced today the launch of Montelukast Sodium IR Tablets (10mg) and Montelukast Sodium Chewable Tablets (4mg & 5mg), generic versions of SINGULAIR Tablets and SINGULAIR Chewable Tablets, respectively.
Like zafirlukast, montelukast is a competitive antagonist for the cysteinyl leukotrienes.
My child went to see a hospital paediatrician and was prescribed montelukast.
Even though all three patients were on prophylactic montelukast (Singulair) at the time of aspirin challenge, the leukotriene receptor antagonist may not provide complete protection in a subset of vulnerable patients.
com/research/rq8jml/investigation) has announced the addition of the "Investigation Report on China Montelukast Market" report to their offering.
A simple saliva test could identify which children carry the offending gene and allow doctors to prescribe an alternative such as Montelukast (also known as Singulair), a pill which is less effective for most children but much better for those who do not respond to Salmeterol.
In the Kingdom, a new line of asthma control drugs known as montelukast sodium is used to prevent asthma attacks in adults and children as young as 12 months old.
Those with the strongest inhibitory effects were the asthma drug montelukast (Singulair), and the protease inhibitors nelfinavir (Viracept) and ritonavir (Norvir), which were associated with 90%-100% inhibition of 17P.
Another study examined the association of ALOX5 promoter genotypes with responses to montelukast therapy.
We conducted a prospective, randomized, placebo-controlled, double-blind study to determine if the leukotriene inhibitor montelukast is effective in eliminating persistent middle ear drainage in patients with otitis media with effusion (OME).
Patients taking antihistamines and decongestants were included in the analysis, but those with active substance-related or psychotic disorders were excluded, as were those taking montelukast or intranasal corticosteroids.
4] receptor antagonist, montelukast (MK-0476), on histologic damage induced by testes I-R in rats.